Fibrinogen.
作者信息
Ernst E
出版信息
BMJ. 1991 Sep 14;303(6803):596-7. doi: 10.1136/bmj.303.6803.596.
Abstract
摘要
相似文献
1
Fibrinogen.
BMJ. 1991 Sep 14;303(6803):596-7. doi: 10.1136/bmj.303.6803.596.
2
[Fibrinogen as an independent risk factor of cardiovascular disease].
Lakartidningen. 1992 Aug 19;89(34):2661-3.
3
[Plasma fibrinogen and cardiovascular disease].
Ugeskr Laeger. 1991 Aug 19;153(34):2343-5.
4
Clinical benefit of fibrinogen evaluation.
Blood Coagul Fibrinolysis. 1999 Feb;10 Suppl 1:S87-9.
5
Fibrinogen as a cardiovascular risk factor.
Rev Port Cardiol. 1997 Mar;16(3):245-50.
6
Fibrinogen: the plot thickens.
J Clin Epidemiol. 1992 May;45(5):561-2. doi: 10.1016/0895-4356(92)90106-w.
7
[Fibrinogen as a cardiovascular risk factor--marker or causal factor?].
Tidsskr Nor Laegeforen. 1999 Aug 20;119(19):2829-32.
8
Fibrinogen and viscosity: risk factors for cardiovascular events.
Compr Ther. 1994;20(3):170-3.
9
[Fibrinogen: cardiovascular risk factor].
Invest Clin. 2002 Dec;43(4):291-301.
10
Fibrinogen and cardiovascular disorders.
QJM. 1995 Mar;88(3):155-65.
引用本文的文献
1
Rates and predictors of stroke-associated case fatality in black Central African patients.
Cardiovasc J Afr. 2008 Mar-Apr;19(2):72-6.
2
The importance of diet and physical activity in the treatment of conditions managed in general practice.
Br J Gen Pract. 1996 Mar;46(404):187-92.
3
Routine measurement of fibrinogen concentration.
BMJ. 1993 Oct 9;307(6909):882-3. doi: 10.1136/bmj.307.6909.882.
4
Effects of different antihypertensive drugs on plasma fibrinogen in hypertensive patients.
Br J Clin Pharmacol. 1995 May;39(5):471-6. doi: 10.1111/j.1365-2125.1995.tb04482.x.
本文引用的文献
1
Fibrinogen as a risk factor for stroke and myocardial infarction.
N Engl J Med. 1984 Aug 23;311(8):501-5. doi: 10.1056/NEJM198408233110804.
2
Hemorrheologic changes following acute myocardial infarction.
Am Heart J. 1982 Dec;104(6):1364-7. doi: 10.1016/0002-8703(82)90169-7.
3
Haemostatic function and cardiovascular death: early results of a prospective study.
Lancet. 1980 May 17;1(8177):1050-4. doi: 10.1016/s0140-6736(80)91498-1.
4
Clinical, haemodynamic, rheological, and biochemical findings in 126 patients with intermittent claudication.
Br Med J. 1973 Dec 8;4(5892):576-81. doi: 10.1136/bmj.4.5892.576.
5
Plasma fibrinogen--a major coronary risk factor.
J R Coll Gen Pract. 1985 Dec;35(281):565-9.
6
Fibrinogen and risk of cardiovascular disease. The Framingham Study.
JAMA. 1987 Sep 4;258(9):1183-6.
7
Changes in blood rheology in patients with stable angina pectoris as a result of coronary artery disease.
Circulation. 1987 Jul;76(1):15-20. doi: 10.1161/01.cir.76.1.15.
8
Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study.
Lancet. 1986 Sep 6;2(8506):533-7. doi: 10.1016/s0140-6736(86)90111-x.
9
Hemorheological effects of oral contraceptives.
Contraception. 1989 Nov;40(5):571-80. doi: 10.1016/0010-7824(89)90129-7.
10
Prediction of carotid stenosis progression by lipid and hematologic measurements.
Neurology. 1989 Oct;39(10):1325-31. doi: 10.1212/wnl.39.10.1325.
Zotero 插件